Mechanism

TrialResults-center.org

Menu

insulin sensitizers - PPAR modulator

treatment

comparator

Aleglitazar

diabetes type 2, in all types of patients

Endpoint	TE [95% CI]	p val	I2	n	k	trials

TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients

Trial	Studied treatment	Control	Patients
ALECARDIO,

Modal title

- About - Browse pathology | treatment - Site map - Credits Made with in Lyon - Contact us - Privacy policy -